Effects of antibiotic stewardship on neonatal bloodstream infections
LIU Xiao-Lu, YANG Jing, CHEN Xin-Hong, HUA Zi-Yu
Department of Neonatology, Children's Hospital of Chongqing Medical University/National Demonstration Base of Standardized Training Base for Resident Physicians/Ministry of Education Key Laboratory of Child Development and Disorders/Key Laboratory of Pediatrics in Chongqing/Chongqing International Science and Technology Cooperation Center for Child Development and Disorders, Chongqing 400014, China
Abstract Objective To investigate the effects of antibiotic stewardship on the pathogen and clinical outcome of neonatal bloodstream infections (BSIs). Methods A retrospective study was performed on neonates with BSIs who were admitted to the neonatal ward in the years of 2010 (pre-stewardship) and 2013 (post-stewardship) for pathogens, antibiotic resistance, antibiotic use, and clinical outcomes. Results The admission rate of BSIs (6.47% vs 2.78%) and the incidence of nosocomial BSIs (0.70% vs 0.30%) in 2013 were significantly higher than in 2010 (P < 0.01). However, there were no signicant differences in the clinical outcomes between the years of 2010 and 2013 (P > 0.05). The four most common pathogens isolated from blood cultures, Staphylococcus haemolyticus, Staphylococcus epidermidis, Klebsiella pneumoniae ssp pneumoniae and E.coli, were similar between the two years. There were no significant differences in the detection rates of extended spectrum β-lactamase-positve Klebsiella pneumoniae ssp pneumoniae or E.coli between the two years. The detection rates of methicillin-resistant Staphylococcus/β-lactamase-positive Staphylococcus haemolyticus and Staphylococcus epidermidis were similar between the two years (P > 0.05). Conclusions Since the implementation of antibiotic stewardship, there has been no marked variation in the common pathogens and their antibacterial resistance in neonatal BSIs. The antibiotic stewardship could promote the recovery of patients with BSIs.
Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I:recent trends and current status[J]. Lancet Infect Dis, 2005, 5(8):481-493.
[2]
Belkina T, Al Warafi A, Hussein Eltom E, et al. Antibiotic use and knowledge in the community of Yemen, Saudi Arabia, and Uzbekistan[J]. J Infect Dev Ctries, 2014, 8(4):424-429.
[3]
Franco BE, Altagracia Martínez M, Sánchez Rodríguez MA, et al. The determinants of the antibiotic resistance process[J]. Infect Drug Resist, 2009, 2:1-11.
[4]
Li Y. China's misuse of antibiotics should be curbed[J]. BMJ, 2014, 348:g1083.
Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality:an updated systematic analysis for 2010 with time trends since 2000[J]. Lancet, 2012, 379(9832):2151-2161.
[7]
UNDP. The millennium development goals report 2013[DB/OL]. (2014-06-05).
[8]
Radulova P. Neonatal infections. Diagnostic markers of infection[J]. Akush Ginekol (Sofiia), 2010, 49(5):42-51.
[9]
Yang YN, Tseng HI, Yang SN, et al. A strategy for reduction of antibiotic use in new patients admitted to a neonatal intensive care unit[J]. Pediatr Neonatol, 2012, 53(4):245-251.
[10]
Yurdakök M. Antibiotic use in neonatal sepsis[J]. Turk J Pediatr, 1998, 40(1):17-33.
[11]
Fanos V, Dall'Agnola A. Antibiotics in neonatal infections:a review[J]. Drugs, 1999, 58(3):405-427.
[12]
Lopes JM, Goulart EM, Siqueira AL, et al. Nosocomial infections in Brazilian pediatric patients:using a decision tree to identify high mortality groups[J]. Braz J Infect Dis, 2009, 13(2):111-117.
Leistner R, Piening B, Gastmeier P, et al. Nosocomial infections in very low birthweight infants in Germany:current data from the National Surveillance System NEO-KISS[J]. Klin Padiatr, 2013, 225(2):75-80.
[15]
Babazono A, Kitajima H, Nishimaki S, et al. Risk factors for nosocomial infection in the neonatal intensive care unit by the Japanese Nosocomial Infection Surveillance (JANIS)[J]. Acta Med Okayama, 2008, 62(4):261-268.
[16]
van der Zwet WC, Kaiser AM, van Elburg RM, et al. Nosocomial infections in a Dutch neonatal intensive care unit:surveillance study with definitions for infection specifically adapted for neonates[J]. J Hosp Infect, 2005, 61(4):300-311.
[17]
Fahmey SS. Early-onset sepsis in a neonatal intensive care unit in Beni Suef, Egypt:bacterial isolates and antibiotic resistance pattern[J]. Korean J Pediatr, 2013, 56(8):332-337.
[18]
Morkel G, Bekker A, Marais BJ, et al. Bloodstream infections and antimicrobial resistance patterns in a South African neonatal intensive care unit[J]. Paediatr Int Child Health, 2014, 34(2):108-114.
Tenover FC. Mechanisms of antimicrobial resistance in bacteria[J]. Am J Infect Control, 2006, 34(5):S3-S10.
[21]
Guilhelmelli F, Vilela N, Albuquerque P, et al. Antibiotic development challenges:the various mechanisms of action of antimicrobial peptides and of bacterial resistance[J]. Front Microbiol, 2013, 4:353.
